Analyst firms · Raymond James · FGEN

Raymond James FGEN price target and rating history

FibroGen Inc (FGEN) · Health Care

Raymond James rates FibroGen Inc (FGEN) Mkt Perform with a $35 price target, as of its latest action on Jun 26, 2023. It has published 3 rating actions on FGEN since August 2021, including 2 upgrades and 1 downgrade.

Current rating
Mkt Perform
Price target
$35
Median target, all firms
Too few
Actions on FGEN
3

Every Raymond James rating on FGEN

Questions about Raymond James and FGEN

What is Raymond James's price target for FGEN?
Raymond James's latest stated price target for FibroGen Inc (FGEN) is $35, from its action on Jan 26, 2023.
What is Raymond James's rating on FGEN?
Raymond James rates FGEN Mkt Perform, a neutral rating, as of Jun 26, 2023.
When did Raymond James last change its view on FGEN?
On Jun 26, 2023, Raymond James downgrades to Mkt Perform from Outperform.

More FGEN rating histories

All Raymond James ratingsFGEN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.